{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:46:52Z","timestamp":1765889212997},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,30]]},"DOI":"10.7759\/cureus.49701","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T11:56:00Z","timestamp":1701345360000},"source":"Crossref","is-referenced-by-count":3,"title":["Assessing the Effect of the Anti-tuberculosis Drug Rifampicin on Known Hypertensive Patients With Tuberculosis in a Tertiary Care Center"],"prefix":"10.7759","author":[{"given":"Yogesh","family":"S","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveenkumar","family":"Nallathambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganapathy Raja","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hariharan","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautham","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shriganesh P","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navvin","family":"S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preetham","family":"Ezhilarasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahimth","family":"JA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suriya Prakash","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.12.016","article-title":"Tuberculosis and hypertension-a systematic review of the literature","volume":"56","author":"Seegert AB","year":"2017","unstructured":"Seegert AB, Rudolf F, Wejse C, Neupane D. Tuberculosis and hypertension-a systematic review of the literature. Int J Infect Dis. 2017, 56:54-61. 10.1016\/j.ijid.2016.12.016","journal-title":"Int J Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-016-0628-7","article-title":"Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence","volume":"18","author":"Caillon A","year":"2016","unstructured":"Caillon A, Schiffrin EL. Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence. Curr Hypertens Rep. 2016, 18:21. 10.1007\/s11906-016-0628-7","journal-title":"Curr Hypertens Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02414-5","article-title":"Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up","volume":"24","author":"Kang JY","year":"2023","unstructured":"Kang JY, Han K, Lee SH, Kim MK. Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up. Respir Res. 2023, 24:110. 10.1186\/s12931-023-02414-5","journal-title":"Respir Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187967","article-title":"Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Al-Rifai RH","year":"2017","unstructured":"Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS One. 2017, 12:e0187967. 10.1371\/journal.pone.0187967","journal-title":"PLoS One"},{"key":"ref5","unstructured":"World Health Organization. Tuberculosis. (2023). https.\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00774","article-title":"Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug","volume":"9","author":"Berger B","year":"2018","unstructured":"Berger B, Bachmann F, Duthaler U, Kr\u00e4henb\u00fchl S, Haschke M. Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug. Front Pharmacol. 2018, 9:774. 10.3389\/fphar.2018.00774","journal-title":"Front Pharmacol"},{"key":"ref7","article-title":"Resistant hypertension during antituberculosis treatment: how is rifampicin implicated?","volume":"75","author":"Lee SL","year":"2020","unstructured":"Lee SL, Lim WJ, Chai ST. Resistant hypertension during antituberculosis treatment: how is rifampicin implicated?. Med J Malaysia. 2020, 75:591-3.","journal-title":"Med J Malaysia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12292","article-title":"Rifampicin reverses nicardipine effect inducing uncontrolled essential hypertension","volume":"31","author":"Cordeanu EM","year":"2017","unstructured":"Cordeanu EM, Gaertner S, Faller A, Mirea C, Lessinger JM, Kemmel V, Stephan D. Rifampicin reverses nicardipine effect inducing uncontrolled essential hypertension. Fundam Clin Pharmacol. 2017, 31:587-9. 10.1111\/fcp.12292","journal-title":"Fundam Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.06.042","article-title":"Drug-drug interactions in the management of patients with pulmonary arterial hypertension","volume":"162","author":"Wu S","year":"2022","unstructured":"Wu S, Hoang HB, Yang JZ, et al.. Drug-drug interactions in the management of patients with pulmonary arterial hypertension. Chest. 2022, 162:1360-72. 10.1016\/j.chest.2022.06.042","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13848","article-title":"Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine","volume":"85","author":"Sunwoo YE","year":"2019","unstructured":"Sunwoo YE, Nguyen PT, Chien CM, Ryu JY, Shon J, Shin JG. Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine. Br J Clin Pharmacol. 2019, 85:737-45. 10.1111\/bcp.13848","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.176145","article-title":"Rifampicin and anti-hypertensive drugs in chronic kidney disease: pharmacokinetic interactions and their clinical impact","volume":"26","author":"Agrawal A","year":"2016","unstructured":"Agrawal A, Agarwal SK, Kaleekal T, Gupta YK. Rifampicin and anti-hypertensive drugs in chronic kidney disease: pharmacokinetic interactions and their clinical impact. Indian J Nephrol. 2016, 26:322-8. 10.4103\/0971-4065.176145","journal-title":"Indian J Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1446","article-title":"The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes","volume":"73","author":"Chidambaram V","year":"2021","unstructured":"Chidambaram V, Gupte A, Wang JY, Golub JE, Karakousis PC. The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes. Clin Infect Dis. 2021, 73:e3409-18. 10.1093\/cid\/ciaa1446","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15534","article-title":"Use of calcium channel blockers and risk of active tuberculosis disease: a population-based analysis","volume":"77","author":"Lee CC","year":"2021","unstructured":"Lee CC, Lee MG, Hsu WT, et al.. Use of calcium channel blockers and risk of active tuberculosis disease: a population-based analysis. Hypertension. 2021, 77:328-37. 10.1161\/HYPERTENSIONAHA.120.15534","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.665785","article-title":"Something old, something new: ion channel blockers as potential anti-tuberculosis agents","volume":"12","author":"Mitini-Nkhoma SC","year":"2021","unstructured":"Mitini-Nkhoma SC, Chimbayo ET, Mzinza DT, et al.. Something old, something new: ion channel blockers as potential anti-tuberculosis agents. Front Immunol. 2021, 12:665785. 10.3389\/fimmu.2021.665785","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/195785-assessing-the-effect-of-the-anti-tuberculosis-drug-rifampicin-on-known-hypertensive-patients-with-tuberculosis-in-a-tertiary-care-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:58Z","timestamp":1707509218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/195785-assessing-the-effect-of-the-anti-tuberculosis-drug-rifampicin-on-known-hypertensive-patients-with-tuberculosis-in-a-tertiary-care-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.49701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}